COVID-19 vaccines: history of the pandemic's great scientific success and flawed policy implementation
- PMID: 38459404
- PMCID: PMC11368972
- DOI: 10.1007/s40592-024-00189-z
COVID-19 vaccines: history of the pandemic's great scientific success and flawed policy implementation
Abstract
The COVID-19 vaccine has been a miraculous, life-saving advance, offering staggering efficacy in adults, and was developed with astonishing speed. The time from sequencing the virus to authorizing the first COVID-19 vaccine was so brisk even the optimists appear close-minded. Yet, simultaneously, United States' COVID-19 vaccination roll-out and related policies have contained missed opportunities, errors, run counter to evidence-based medicine, and revealed limitations in the judgment of public policymakers. Misplaced utilization, contradictory messaging, and poor deployment in those who would benefit most-the elderly and high-risk-alongside unrealistic messaging, exaggeration, and coercion in those who benefit least-young, healthy Americans-is at the heart. It is important to consider the history of COVID-19 vaccines to identify where we succeeded and where we failed, and the effects that these errors may have more broadly on vaccination hesitancy and routine childhood immunization programs in the decades to come.
Keywords: COVID-19; Health policy; Vaccinations.
© 2024. The Author(s).
Conflict of interest statement
V.P. receives research funding from Arnold Ventures through a grant made to UCSF, and royalties for books and writing from Johns Hopkins Press, MedPage, and the Free Press. He declares consultancy roles with UnitedHealthcare and OptumRX; He hosts the podcasts, Plenary Session, VPZD, Sensible Medicine, writes the newsletters, Sensible Medicine, the Drug Development Letter and VP's Observations and Thoughts, and runs the YouTube channel Vinay Prasad MD MPH, which collectively earn revenue on the platforms: Patreon, YouTube and Substack.
Figures
Similar articles
-
Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults.BMC Public Health. 2022 May 25;22(1):1047. doi: 10.1186/s12889-022-13477-2. BMC Public Health. 2022. PMID: 35614396 Free PMC article.
-
Knowledge and Behaviours towards Immunisation Programmes: Vaccine Hesitancy during the COVID-19 Pandemic Era.Int J Environ Res Public Health. 2022 Apr 5;19(7):4359. doi: 10.3390/ijerph19074359. Int J Environ Res Public Health. 2022. PMID: 35410045 Free PMC article.
-
Adherence to Immunization: Rebuttal of Vaccine Hesitancy.Acta Haematol. 2021;144(4):413-417. doi: 10.1159/000511760. Epub 2020 Nov 17. Acta Haematol. 2021. PMID: 33202404 Free PMC article. Review.
-
Implementation of State Vaccine Incentive Lottery Programs and Uptake of COVID-19 Vaccinations in the United States.JAMA Netw Open. 2021 Dec 1;4(12):e2138238. doi: 10.1001/jamanetworkopen.2021.38238. JAMA Netw Open. 2021. PMID: 34882179 Free PMC article.
-
Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy.Mayo Clin Proc. 2021 Mar;96(3):699-707. doi: 10.1016/j.mayocp.2020.12.024. Epub 2020 Dec 30. Mayo Clin Proc. 2021. PMID: 33673921 Free PMC article. Review.
Cited by
-
COVID-19 and Transplant Patients: Challenges, Risks, and Evolving Strategies.Vaccines (Basel). 2025 Mar 17;13(3):318. doi: 10.3390/vaccines13030318. Vaccines (Basel). 2025. PMID: 40266237 Free PMC article.
-
Treatment and Outcomes of COVID-19 Infection in Pregnant Women: Systematic Review of Cases Reported in Europe.J Clin Med. 2025 May 27;14(11):3743. doi: 10.3390/jcm14113743. J Clin Med. 2025. PMID: 40507506 Free PMC article. Review.
-
Analysis of the Political Viewpoint of Policy Statements From Professional Medical Organizations Using ChatGPT With GPT-4: Cross-Sectional Study.JMIR Form Res. 2025 Jun 13;9:e66204. doi: 10.2196/66204. JMIR Form Res. 2025. PMID: 40513086 Free PMC article.
-
The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic.Med Health Care Philos. 2024 Mar;27(1):49-70. doi: 10.1007/s11019-023-10184-6. Epub 2023 Dec 28. Med Health Care Philos. 2024. PMID: 38153559 Free PMC article.
-
EXPERTISE, DISAGREEMENT, and TRUST IN VACCINE SCIENCE AND POLICY. The importance of transparency in a world of experts.Diametros. 2025 Feb 27;22(82):7-27. doi: 10.33392/diam.1871. Diametros. 2025. PMID: 39404699 Free PMC article.
References
-
- @VPrasadMDMPH (Vinay Prasad). 2021. Yesterday I said the J&J vaccine is Game Over for women 18–50, with 6 cases in 1.4 million vaccinated in that age group (~1/200k), here is why I say that.... Twitter. https://twitter.com/vprasadmdmph/status/1382734864219140100.
-
- Andrews, N., E. Tessier, J. Stowe, C. Gower, F. Kirsebom, R. Simmons, E. Gallagher, S. Thelwall, N. Groves, G. Dabrera, R. Myers, C.N.J. Campbell, G. Amirthalingam, M. Edmunds, M. Zambon, K. Brown, S. Hopkins, M. Chand, S.N. Ladhani, and J. Lopez Bernal. 2022. Duration of protection against mild and severe disease by covid-19 vaccines. The New England Journal of Medicine 386 (4): 340–350. 10.1056/NEJMoa2115481. 10.1056/NEJMoa2115481 - DOI - PMC - PubMed
-
- Approval letter: BNT162b2. 2021.
-
- Australian Government. 2023. COVID-19 booster vaccine advice. Australian Government Department of Health and Aged Care. https://www.health.gov.au/our-work/covid-19-vaccines/getting-your-vaccin...
-
- Baden, L. R., H. M. El Sahly, B. Essink, K. Kotloff, S. Frey, R. Novak, D. Diemert, S. A. Spector, N. Rouphael, C. B. Creech, J. McGettigan, S. Khetan, N. Segall, J. Solis, A. Brosz, C. Fierro, H. Schwartz, K. Neuzil, L. Corey, COVE Study Group. 2021. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. The New England Journal of Medicine, 384(5), 403–416. 10.1056/NEJMoa2035389. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical